• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶组织内阿米巴病疫苗的开发:以 Gal/GalNAc 凝集素为重点的 E. histolytica 简述

Amoebiasis vaccine development: A snapshot on E. histolytica with emphasis on perspectives of Gal/GalNAc lectin.

机构信息

Carbohydrate and Protein Biotechnology Laboratory, Department of Biotechnology, Punjabi University, Patiala 147002, Punjab, India.

Carbohydrate and Protein Biotechnology Laboratory, Department of Biotechnology, Punjabi University, Patiala 147002, Punjab, India.

出版信息

Int J Biol Macromol. 2016 Oct;91:258-68. doi: 10.1016/j.ijbiomac.2016.05.043. Epub 2016 May 12.

DOI:10.1016/j.ijbiomac.2016.05.043
PMID:27181579
Abstract

Amoebiasis/amebiasis is a gastrointestinal infection caused by an enteric dwelling protozoan, Entamoeba histolytica. The disease is endemic in the developing world and is transmitted mainly via the faecal-oral route (e.g., in water or food) and may or may not be symptomatic. This disease of socio-economic importance worldwide involves parasite adherence and cytolysis of human cells followed by invasion that is mediated by galactose-binding (Gal/GalNAc) surface lectin. Disruption of the mucus layer leads to invasive intestinal and extraintestinal infection. Gal-lectin based vaccinations have conferred protection in various animal models against E. histolytica infections. Keeping in view the pivotal role of Gal/GalNAc lectin in amoebiasis vaccine development, its regulation, genomic view of the parasite involving gene conversion in lectin gene families, current knowledge about involvement of Gal/GalNAc lectin in adherence, pathogenicity, signalling, encystment, generating host immune response, and in turn protozoa escape strategies, and finally its role as effective vaccine candidate has been described. This review will help researchers to explore pathogenesis mechanism along with genomic studies and will also provide a framework for future amoebiasis vaccine development studies.

摘要

溶组织内阿米巴病是一种由肠道居住的原生动物溶组织内阿米巴引起的胃肠道感染。这种疾病在发展中国家流行,主要通过粪-口途径(例如在水或食物中)传播,可能有症状,也可能无症状。这种具有社会经济重要性的全球性疾病涉及寄生虫黏附和人细胞的溶解,随后通过半乳糖结合(Gal/GalNAc)表面凝集素介导的侵袭。黏液层的破坏导致侵袭性肠道和肠道外感染。基于半乳糖凝集素的疫苗已在各种动物模型中对溶组织内阿米巴感染提供了保护。鉴于 Gal/GalNAc 凝集素在阿米巴病疫苗开发中的关键作用,其调控、寄生虫基因转换涉及凝集素基因家族的基因组视图、Gal/GalNAc 凝集素在黏附、致病性、信号转导、囊包形成、产生宿主免疫反应以及反过来原生动物逃避策略中的作用,以及最后其作为有效疫苗候选物的作用,都已被描述。这篇综述将帮助研究人员探索发病机制,以及基因组研究,并为未来的阿米巴病疫苗开发研究提供框架。

相似文献

1
Amoebiasis vaccine development: A snapshot on E. histolytica with emphasis on perspectives of Gal/GalNAc lectin.溶组织内阿米巴病疫苗的开发:以 Gal/GalNAc 凝集素为重点的 E. histolytica 简述
Int J Biol Macromol. 2016 Oct;91:258-68. doi: 10.1016/j.ijbiomac.2016.05.043. Epub 2016 May 12.
2
Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.溶组织内阿米巴半乳糖/ N - 乙酰半乳糖胺凝集素中间亚基C末端片段作为抗阿米巴肝脓肿疫苗候选物的评估
PLoS Negl Trop Dis. 2016 Jan 29;10(1):e0004419. doi: 10.1371/journal.pntd.0004419. eCollection 2016 Jan.
3
The galactose-inhibitable surface lectin of Entamoeba histolytica, a possible candidate for a subunit vaccine to prevent amoebiasis.溶组织内阿米巴的半乳糖抑制性表面凝集素,一种预防阿米巴病的亚单位疫苗的可能候选物。
Behring Inst Mitt. 1997 Mar(99):112-6.
4
Prospect for an Entamoeba histolytica Gal-lectin-based vaccine.基于溶组织内阿米巴半乳糖凝集素的疫苗的前景。
Parasite Immunol. 2003 Feb;25(2):55-8. doi: 10.1046/j.1365-3024.2003.00607.x.
5
Construction and immunogenicity of a codon-optimized Entamoeba histolytica Gal-lectin-based DNA vaccine.
Vaccine. 2002 Sep 10;20(27-28):3244-53. doi: 10.1016/s0264-410x(02)00303-1.
6
Activation of dendritic cells by the Gal-lectin of Entamoeba histolytica drives Th1 responses in vitro and in vivo.溶组织内阿米巴的半乳糖凝集素激活树突状细胞可在体外和体内驱动Th1反应。
Eur J Immunol. 2007 Feb;37(2):385-94. doi: 10.1002/eji.200636476.
7
Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge.用Gal抑制性凝集素加CpG寡脱氧核苷酸佐剂进行鼻内免疫可预防溶组织内阿米巴攻击。
Infect Immun. 2007 Oct;75(10):4917-22. doi: 10.1128/IAI.00725-07. Epub 2007 Jul 9.
8
Entamoeba histolytica: from adherence to enteropathy.溶组织内阿米巴:从黏附到肠病
J Infect Dis. 1989 Mar;159(3):420-9. doi: 10.1093/infdis/159.3.420.
9
Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.用溶组织内阿米巴Gal/GalNac凝集素疫苗预防肠道阿米巴病。
Vaccine. 2004 Jan 26;22(5-6):611-7. doi: 10.1016/j.vaccine.2003.09.003.
10
Opportunities and obstacles in developing a vaccine for Entamoeba histolytica.开发溶组织内阿米巴疫苗的机遇与障碍。
Curr Opin Immunol. 2002 Oct;14(5):549-52. doi: 10.1016/s0952-7915(02)00372-2.

引用本文的文献

1
Molecular interplays of the endosomal sorting complexes required for transport during phagocytosis.吞噬作用过程中内体分选复合物所需运输的分子相互作用。
Front Cell Infect Microbiol. 2022 Oct 27;12:855797. doi: 10.3389/fcimb.2022.855797. eCollection 2022.
2
Quantitative Proteomics Reveals Metabolic Reprogramming in Host Cells Induced by Trophozoites and Intermediate Subunit of Gal/GalNAc Lectins from Entamoeba histolytica.定量蛋白质组学揭示了溶组织内阿米巴滋养体和半乳糖/ N -乙酰半乳糖凝集素中间亚基诱导的宿主细胞代谢重编程。
mSystems. 2022 Apr 26;7(2):e0135321. doi: 10.1128/msystems.01353-21. Epub 2022 Mar 28.
3
Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.
重新审视针对被忽视热带病——阿米巴病的药物研发。
Front Cell Infect Microbiol. 2021 Feb 24;10:628257. doi: 10.3389/fcimb.2020.628257. eCollection 2020.
4
Antiprotozoal Activity against of Flavonoids Isolated from Kunth.从 Kunth 中分离得到的类黄酮的抗原生动物活性。
Molecules. 2020 May 26;25(11):2464. doi: 10.3390/molecules25112464.
5
Epithelial Cells Expressing EhADH, An Adhesin, Exhibit Increased Tight Junction Proteins.表达 EhADH 黏附素的上皮细胞表达增加的紧密连接蛋白。
Front Cell Infect Microbiol. 2018 Sep 28;8:340. doi: 10.3389/fcimb.2018.00340. eCollection 2018.
6
Functional Expression and Characterization of the Recombinant N-Acetyl-Glucosamine/N-Acetyl-Galactosamine-Specific Marine Algal Lectin BPL3.重组 N-乙酰氨基葡萄糖/N-乙酰氨基半乳糖特异性海洋藻类凝集素 BPL3 的功能表达与表征。
Mar Drugs. 2018 Jan 5;16(1):13. doi: 10.3390/md16010013.